// App-Quantinova.ai

BSH19‐PO‐114 : A single centre study to estimate the follow up of patients with monoclonal gammopathy of undetermined significance by community physicians in the UK

Researchers

Presenter

  • I. Ramasamy

Principal Investigators

  • N/A

Medical Centers

  • Department of Biochemistry, Worcester Royal Hospital, Worcester, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Oncology (ONC)

Disease

  • Lympho proliferative disease

  • Monoclonal gammopathy

Biomarkers

  • Cluster of differentiation 79A

  • Immunoglobulin G

  • Monoclonal gammopathy of undetermined significance

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved